{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:40:46Z","timestamp":1768423246189,"version":"3.49.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.ucl.2010.06.001","type":"journal-article","created":{"date-parts":[[2010,10,17]],"date-time":"2010-10-17T04:13:53Z","timestamp":1287288833000},"page":"567-580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Botulinum Toxin Therapy for Neurogenic Detrusor Overactivity"],"prefix":"10.1016","volume":"37","author":[{"given":"Marc C.","family":"Smaldone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin T.","family":"Ristau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy W.","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ucl.2010.06.001_bib1","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2010.06.001_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","article-title":"The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society","volume":"61","author":"Abrams","year":"2003","journal-title":"Urology"},{"issue":"11","key":"10.1016\/j.ucl.2010.06.001_bib3","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/j.1464-410X.2008.07601.x","article-title":"The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study","volume":"101","author":"Coyne","year":"2008","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.ucl.2010.06.001_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.urology.2008.12.077","article-title":"Burden of illness associated with lower urinary tract symptoms including overactive bladder\/urinary incontinence","volume":"74","author":"Kannan","year":"2009","journal-title":"Urology"},{"issue":"2 Pt 2","key":"10.1016\/j.ucl.2010.06.001_bib5","first-page":"700","article-title":"Stress leak point pressure: a diagnostic tool for incontinent children","volume":"150","author":"Wan","year":"1993","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.ucl.2010.06.001_bib6","first-page":"205","article-title":"Prognostic value of urodynamic testing in myelodysplastic patients","volume":"126","author":"McGuire","year":"1981","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2010.06.001_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/nau.20852","article-title":"Neurologic urinary incontinence","volume":"29","author":"Wyndaele","year":"2010","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"10.1016\/j.ucl.2010.06.001_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.sc.3101584","article-title":"Intravesical therapy options for neurogenic detrusor overactivity","volume":"42","author":"Reitz","year":"2004","journal-title":"Spinal Cord"},{"key":"10.1016\/j.ucl.2010.06.001_bib9","first-page":"1","article-title":"Ueber einen neuen anaeroben bacillus und seine beziehungen zum botulismus","volume":"26","author":"van Ermengem","year":"1897","journal-title":"Zeitsch Hyg Infekt"},{"issue":"3","key":"10.1016\/j.ucl.2010.06.001_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0031-6997(25)06852-8","article-title":"The origin, structure, and pharmacological activity of botulinum toxin","volume":"33","author":"Simpson","year":"1981","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.ucl.2010.06.001_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1590\/S0004-282X2005000100035","article-title":"Botulinum toxin: mechanisms of action","volume":"63","author":"Dressler","year":"2005","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"10.1016\/j.ucl.2010.06.001_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/jnnp.33.1.40","article-title":"Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of the mouse: differences between fast and slow muscles","volume":"33","author":"Duchen","year":"1970","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"32","key":"10.1016\/j.ucl.2010.06.001_bib13","doi-asserted-by":"crossref","first-page":"23784","DOI":"10.1016\/S0021-9258(20)80452-9","article-title":"Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E","volume":"268","author":"Schiavo","year":"1993","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.ucl.2010.06.001_bib14","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","article-title":"Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity","volume":"49","author":"Apostolidis","year":"2006","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ucl.2010.06.001_bib15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.urology.2004.06.073","article-title":"Botulinum toxin a has antinociceptive effects in treating interstitial cystitis","volume":"64","author":"Smith","year":"2004","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.ucl.2010.06.001_bib16","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","article-title":"Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder","volume":"46","author":"Haferkamp","year":"2004","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ucl.2010.06.001_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2005.06.011","article-title":"Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases","volume":"53","author":"Cote","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.ucl.2010.06.001_bib18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1464-410X.2009.08466.x","article-title":"Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study","volume":"104","author":"Grosse","year":"2009","journal-title":"BJU Int"},{"issue":"31","key":"10.1016\/j.ucl.2010.06.001_bib19","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.2174\/138161209789271843","article-title":"Current clinical applications of botulinum toxin","volume":"15","author":"Truong","year":"2009","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10.1016\/j.ucl.2010.06.001_bib20","first-page":"919","article-title":"Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients","volume":"139","author":"Dykstra","year":"1988","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ucl.2010.06.001_bib21","first-page":"1023","article-title":"Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients","volume":"155","author":"Schurch","year":"1996","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ucl.2010.06.001_bib22","first-page":"984","article-title":"A\u00a0comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin","volume":"174","author":"Popat","year":"2005","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2010.06.001_bib23","first-page":"196","article-title":"Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study","volume":"174","author":"Schurch","year":"2005","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2010.06.001_bib24","first-page":"177","article-title":"Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics","volume":"176","author":"Schmid","year":"2006","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2010.06.001_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2008.09.009","article-title":"Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report","volume":"55","author":"Apostolidis","year":"2009","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2010.06.001_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.urology.2004.08.016","article-title":"Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra","volume":"65","author":"Smith","year":"2005","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.ucl.2010.06.001_bib27","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.eururo.2007.08.052","article-title":"Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity","volume":"52","author":"Reitz","year":"2007","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ucl.2010.06.001_bib28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","article-title":"Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"53","author":"Karsenty","year":"2008","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ucl.2010.06.001_bib29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1590\/S1677-55382007000200002","article-title":"Botulinum toxin injection: a review of injection principles and protocols","volume":"33","author":"Rapp","year":"2007","journal-title":"Int Braz J Urol"},{"issue":"3 Pt 1","key":"10.1016\/j.ucl.2010.06.001_bib30","first-page":"692","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ucl.2010.06.001_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005493.pub2","article-title":"Botulinum toxin injections for adults with overactive bladder syndrome","author":"Duthie","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ucl.2010.06.001_bib32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1017\/S0012162203000380","article-title":"Effect of muscle activity and botulinum toxin dilution volume on muscle paralysis","volume":"45","author":"Kim","year":"2003","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"10.1016\/j.ucl.2010.06.001_bib33","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1089\/end.2005.19.880","article-title":"Simplified bladder botulinum-toxin delivery technique using flexible cystoscope and 10 sites of injection","volume":"19","author":"Smith","year":"2005","journal-title":"J\u00a0Endourol"},{"issue":"5","key":"10.1016\/j.ucl.2010.06.001_bib34","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.eururo.2007.09.034","article-title":"Neurogenic detrusor overactivity treated with English botulinum toxin a: 8-year experience of one single centre","volume":"53","author":"Del Popolo","year":"2008","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ucl.2010.06.001_bib35","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ucl.2010.06.001_bib36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000251175","article-title":"Treatment of neurogenic detrusor overactivity with botulinum toxin A: the first seven years","volume":"83","author":"Stoehrer","year":"2009","journal-title":"Urol Int"},{"issue":"4","key":"10.1016\/j.ucl.2010.06.001_bib37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/00365590601068835","article-title":"Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: a randomised, placebo-controlled, double-blind study","volume":"41","author":"Ehren","year":"2007","journal-title":"Scand J Urol Nephrol"},{"issue":"1","key":"10.1016\/j.ucl.2010.06.001_bib38","first-page":"79","article-title":"New therapeutic options for refractory neurogenic detrusor overactivity","volume":"56","author":"Giannantoni","year":"2004","journal-title":"Minerva Urol Nefrol"},{"issue":"6","key":"10.1016\/j.ucl.2010.06.001_bib39","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/00365590410015867","article-title":"Botulinum toxin A for treatment of neurogenic detrusor overactivity and incontinence in patients with spinal cord lesions","volume":"38","author":"Bagi","year":"2004","journal-title":"Scand J Urol Nephrol"},{"issue":"6","key":"10.1016\/j.ucl.2010.06.001_bib40","first-page":"2341","article-title":"Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity","volume":"175","author":"Giannantoni","year":"2006","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ucl.2010.06.001_bib41","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","article-title":"Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results","volume":"55","author":"Giannantoni","year":"2009","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2010.06.001_bib42","first-page":"2543","article-title":"Efficacy of botulinum-A toxin in adults with neurogenic overactive bladder: initial results","volume":"12","author":"Hajebrahimi","year":"2005","journal-title":"Can J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2010.06.001_bib43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1464-410X.2003.04312.x","article-title":"A\u00a0minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity","volume":"92","author":"Harper","year":"2003","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ucl.2010.06.001_bib44","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1464-410X.2009.08368.x","article-title":"Patients\u2019 perspective of botulinum toxin-A as a long-term treatment option for neurogenic detrusor overactivity secondary to spinal cord injury","volume":"104","author":"Hori","year":"2009","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ucl.2010.06.001_bib45","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eururo.2005.12.012","article-title":"Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes","volume":"49","author":"Kalsi","year":"2006","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ucl.2010.06.001_bib46","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.urology.2006.08.1069","article-title":"Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity","volume":"68","author":"Karsenty","year":"2006","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ucl.2010.06.001_bib47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","article-title":"Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?","volume":"24","author":"Kessler","year":"2005","journal-title":"Neurourol Urodyn"},{"issue":"11","key":"10.1016\/j.ucl.2010.06.001_bib48","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.apmr.2005.06.008","article-title":"Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions","volume":"86","author":"Klaphajone","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"issue":"5","key":"10.1016\/j.ucl.2010.06.001_bib49","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","article-title":"Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents","volume":"63","author":"Kuo","year":"2004","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.ucl.2010.06.001_bib50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.urology.2005.08.016","article-title":"Therapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions","volume":"67","author":"Kuo","year":"2006","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.ucl.2010.06.001_bib51","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/j.1464-410X.2009.08600.x","article-title":"Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction","volume":"104","author":"Pannek","year":"2009","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.ucl.2010.06.001_bib52","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/nau.20153","article-title":"Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis","volume":"25","author":"Schulte-Baukloh","year":"2006","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"10.1016\/j.ucl.2010.06.001_bib53","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2005.11.006","article-title":"Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre","volume":"49","author":"Kalsi","year":"2006","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ucl.2010.06.001_bib54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/01952307.1985.11785932","article-title":"Urodynamics and management of the neuropathic bladder in spinal cord injury patients","volume":"8","author":"McGuire","year":"1985","journal-title":"J\u00a0Am Paraplegia Soc"},{"issue":"6","key":"10.1016\/j.ucl.2010.06.001_bib55","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.urology.2004.01.041","article-title":"Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience","volume":"63","author":"Rapp","year":"2004","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.ucl.2010.06.001_bib56","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","article-title":"Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence","volume":"47","author":"Grosse","year":"2005","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ucl.2010.06.001_bib57","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1442-2042.2008.02016.x","article-title":"Botulinum neurotoxin type A in urology: antibodies as a cause of therapy failure","volume":"15","author":"Schulte-Baukloh","year":"2008","journal-title":"Int J Urol"},{"issue":"6","key":"10.1016\/j.ucl.2010.06.001_bib58","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00192-003-1099-3","article-title":"Treatment of overactive bladder with botulinum toxin type B: a pilot study","volume":"14","author":"Dykstra","year":"2003","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"2 Pt 1","key":"10.1016\/j.ucl.2010.06.001_bib59","first-page":"802","article-title":"Botulinum toxin type B for type A resistant bladder spasticity","volume":"171","author":"Pistolesi","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"2 Pt 1","key":"10.1016\/j.ucl.2010.06.001_bib60","first-page":"804","article-title":"Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity","volume":"171","author":"Reitz","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.ucl.2010.06.001_bib61","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/nau.20611","article-title":"Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units","volume":"28","author":"Cohen","year":"2009","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"10.1016\/j.ucl.2010.06.001_bib62","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.suc.2006.01.003","article-title":"Bladder management for patients with myelodysplasia","volume":"86","author":"Carr","year":"2006","journal-title":"Surg Clin North Am"},{"issue":"5 Pt 1","key":"10.1016\/j.ucl.2010.06.001_bib63","first-page":"1582","article-title":"Nonsurgical management of threatened upper urinary tracts and incontinence in children with myelomeningocele","volume":"152","author":"Hernandez","year":"1994","journal-title":"J\u00a0Urol"},{"issue":"3 Pt 1","key":"10.1016\/j.ucl.2010.06.001_bib64","first-page":"1102","article-title":"Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele","volume":"175","author":"Altaweel","year":"2006","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.ucl.2010.06.001_bib65","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.urology.2006.05.056","article-title":"Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele","volume":"68","author":"Kajbafzadeh","year":"2006","journal-title":"Urology"},{"issue":"2 Pt 1","key":"10.1016\/j.ucl.2010.06.001_bib66","first-page":"845","article-title":"Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia","volume":"171","author":"Riccabona","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.ucl.2010.06.001_bib67","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.urology.2005.05.054","article-title":"Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity","volume":"66","author":"Schulte-Baukloh","year":"2005","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ucl.2010.06.001_bib68","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0090-4295(01)01641-7","article-title":"Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results","volume":"59","author":"Schulte-Baukloh","year":"2002","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ucl.2010.06.001_bib69","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0302-2838(03)00136-2","article-title":"Botulinum-A toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder","volume":"44","author":"Schulte-Baukloh","year":"2003","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ucl.2010.06.001_bib70","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jpurol.2009.01.005","article-title":"Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"5","author":"Game","year":"2009","journal-title":"J\u00a0Pediatr Urol"},{"issue":"9","key":"10.1016\/j.ucl.2010.06.001_bib71","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200003023420918","article-title":"Treatment of neurogenic incontinence with botulinum toxin A","volume":"342","author":"Schurch","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ucl.2010.06.001_bib72","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ncpuro0521","article-title":"Management of detrusor-external sphincter dyssynergia","volume":"3","author":"Ahmed","year":"2006","journal-title":"Nat Clin Pract Urol"},{"issue":"5","key":"10.1016\/j.ucl.2010.06.001_bib73","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11934-007-0030-8","article-title":"Hitting below the belt (bladder): botulinum treatment of urethral and prostate disorders","volume":"8","author":"Lai","year":"2007","journal-title":"Curr Urol Rep"},{"issue":"1","key":"10.1016\/j.ucl.2010.06.001_bib74","first-page":"24","article-title":"Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study","volume":"71","author":"Dykstra","year":"1990","journal-title":"Arch Phys Med Rehabil"},{"issue":"12","key":"10.1016\/j.ucl.2010.06.001_bib75","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/jnnp.2004.045765","article-title":"Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients","volume":"76","author":"Gallien","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"1","key":"10.1016\/j.ucl.2010.06.001_bib76","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.urology.2006.08.1117","article-title":"Recovery of detrusor function after urethral botulinum A toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction","volume":"69","author":"Kuo","year":"2007","journal-title":"Urology"},{"issue":"4 Pt 1","key":"10.1016\/j.ucl.2010.06.001_bib77","first-page":"1529","article-title":"Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats","volume":"172","author":"Chuang","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.ucl.2010.06.001_bib78","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/01.AOG.0000237100.29870.cc","article-title":"Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial","volume":"108","author":"Abbott","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ucl.2010.06.001_bib79","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0090-4295(03)00477-1","article-title":"Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study","volume":"62","author":"Maria","year":"2003","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.ucl.2010.06.001_bib80","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000020314","article-title":"Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain?","volume":"38","author":"Zermann","year":"2000","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2010.06.001_bib81","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s001920200013","article-title":"Botulinum toxin urethral sphincter injection resolves urinary retention after pubovaginal sling operation","volume":"13","author":"Smith","year":"2002","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"2","key":"10.1016\/j.ucl.2010.06.001_bib82","first-page":"574","article-title":"Botulinum toxin type A: a novel approach to the treatment of recurrent urethral strictures","volume":"172","author":"Khera","year":"2004","journal-title":"J\u00a0Urol"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014310000583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014310000583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:23:44Z","timestamp":1758806624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014310000583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0094014310000583"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2010.06.001","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum Toxin Therapy for Neurogenic Detrusor Overactivity","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2010.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}